DEVERSIFY LAUNCHES IN SPAIN AND PORTUGAL
Deversify takes the next step in Europe and enters the Spanish and Portuguese markets. The launch begins in Spain now in March, where Acetrack, Deversify's breathalyser that measures fat burning, will be launched. The expansion takes place in collaboration with EIT Health's Bridgehead Programme, which aims to facilitate market entry for European health entrepreneurs with the support of top local incubators and catalysts.
Deversify creates educational programs around metabolic health and is world leading on the measurement of biomarkers in exhaled air. The expansion will increase Deversify’s sales potential, serve to improve public health in the region and has been supported by EIT Health’s Bridgehead Programme and the Spanish and Portuguese leading catalysts Leitat, Tec Labs and LabToMarket.
"It is a big step for us to be established in Spain now as the first country in the Spanish-speaking world and in Portugal. It has been a pleasure working with all the catalysts. Thank you EIT Health for making this possible.”, says Anders Murman, CEO and Co-Founder, Deversify.
“Being the catalyst for a Swedish health project like Acetrack that helps people better understand their health has been a very positive experience. Through our strategic expertise, we have been able to help this international project for market entry in Spain, giving them value.", says Anna Gómez, Area Manager, Leitat.
"We at Tec Labs, the Portuguese catalyst for the programme and our partner LabToMarket are very happy to support Deversify in their launching process in Portugal. Our role has been revolving around medical-commercial validation by important KOLs, and we also reached out to key influencers in the medical and nutritional fields. We are confident that this innovative product will be well received by our community", says Sofia Araújo, Incubation Manager, Tec Labs.
Contact:
Anders Murman, CEO, Deversify
anders.murman@deversify.com
+46 70 546 50 62
deversify.com
getacetrack.com
elitista.se
About Deversify:
Deversify is a Swedish R&D company offering health-tech solutions for consumers. We develop and commercialise mobile electronic devices and apps to monitor biomarkers for individualised health. Our vision is for everyone to understand their own health. We specialise in breathalysers and education about nutrition and metabolism. Deversify’s goal is to become the world’s leading provider of consumer health products for evidence-based wellness and improved public health.
About Leitat, Tec Labs and LabToMarket:
Leitat – www.leitat.org
Tec Labs – www.teclabs.pt
LabToMarket – www.labtomarket.eu
